DCM Shriram Fine Chemicals ratifies ₹3.02 lakh fine to exchanges for LODR breach

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • DCM Shriram Fine Chemicals ratifies ₹3,02,080 fine to BSE and NSE each
  • Penalty relates to delayed compliance with SEBI LODR Regulation 17(1)
  • Non-compliance existed during Q2FY26 due to vacant independent director seat
  • Gap resolved with appointment of Nitin Atroley effective July 15, 2026
powered bylight_fuzz_icon
51538724

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals board ratified the payment of ₹3,02,080 to both BSE and NSE on September 21, 2026, settling penalties for non-compliance with SEBI’s Listing Obligations and Disclosure Requirements (LODR). The fines address a temporary gap in independent director representation during Q2FY27.

The company disclosed that the non-compliance stemmed from delays in identifying a suitable candidate for the position of Independent Director. This gap affected compliance with Regulation 17(1) of the SEBI (LODR) Regulations, 2015, for the quarter ended June 30, 2026.

Compliance Timeline

The board noted that the requirement under Regulation 17(1A) had been complied with on May 29, 2026. However, the violation of Regulation 17(1) persisted until the appointment of Mr. Nitin Atroley as Independent Director effective July 15, 2026.

Regulation Status Date Complied Fine Amount
LODR Reg 17(1A) Compliant May 29, 2026 ₹3,02,080 (to each exchange)
LODR Reg 17(1) Delayed July 15, 2026 ₹3,02,080 (to each exchange)

Company Secretary Kokila Arora confirmed that the company was fully compliant with applicable provisions as of the date the exchange notices were received on August 25, 2026.

Board Directive

The board took the notices on record and approved the management’s decision to pay the fines to conclude the matter. It directed management to ensure strict adherence to all SEBI (LODR) regulations moving forward to prevent recurrence.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+4.97%+10.96%+5.50%+17.52%-42.23%-42.23%

Will DCM Shriram Fine Chemicals implement new internal governance protocols or third-party audits to prevent future gaps in independent director representation?

How might this regulatory penalty impact the company's credit ratings or investor confidence in its corporate governance framework?

Are there any pending legal repercussions or additional scrutiny from SEBI regarding the delay in appointing Mr. Nitin Atroley?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like18
dislike

DCM Shriram Fine Chemicals accepts Vijay Anand resignation as director

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Vijay Anand resigns as independent director effective September 17, 2026
  • Cites increased professional obligations and limited time for board duties
  • Holds chairman roles across multiple committees at Pondy Oxides and Chemicals
  • Also serves as chairman of audit and nomination committees at Sasmos HET Technologies
  • Resignation filed under SEBI LODR Regulation 30 with no other material reasons cited
powered bylight_fuzz_icon
51188899

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals accepted the resignation of Vijay Anand as an independent director effective September 17, 2026. The departure follows Anand’s citation of pressing professional commitments limiting his board availability.

The company disclosed the move under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Anand confirmed in his resignation letter that no other material reasons influenced his decision to step down.

Director Profile and Other Roles

Anand continues to hold significant positions in other listed entities. His current directorships include:

  • Pondy Oxides and Chemicals Limited: Chairman of the Audit Committee, Stakeholders’ Relationship Committee, Nomination and Remuneration Committee, Risk Management Committee, and Corporate Social Responsibility Committee.
  • Sasmos HET Technologies Limited: Chairman of the Audit Committee and Nomination and Remuneration Committee.

Regulatory Compliance

The filing aligns with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Kokila Arora, Company Secretary and Compliance Officer, signed the intimation.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+4.97%+10.96%+5.50%+17.52%-42.23%-42.23%

Will DCM Shriram Fine Chemicals initiate a search for a new independent director immediately, and what is the expected timeline for board replenishment?

How might Vijay Anand's departure impact the composition and effectiveness of the Audit and Nomination committees at Pondy Oxides and Sasmos HET Technologies?

Are there any pending strategic decisions or regulatory filings at DCM Shriram that could be delayed or affected by this change in board leadership?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like18
dislike

More News on DCM Shriram Fine Chemicals

1 Year Returns:-42.23%